LT3484907T - Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas - Google Patents

Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas

Info

Publication number
LT3484907T
LT3484907T LTEP17754482.2T LT17754482T LT3484907T LT 3484907 T LT3484907 T LT 3484907T LT 17754482 T LT17754482 T LT 17754482T LT 3484907 T LT3484907 T LT 3484907T
Authority
LT
Lithuania
Prior art keywords
same
rna molecule
phosphotriazole
mrna
peptide
Prior art date
Application number
LTEP17754482.2T
Other languages
English (en)
Inventor
Sylwia WALCZAK
Joanna Kowalska
Jacek Jemielity
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Publication of LT3484907T publication Critical patent/LT3484907T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
LTEP17754482.2T 2016-07-16 2017-07-12 Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas LT3484907T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL417980A PL417980A1 (pl) 2016-07-16 2016-07-16 Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu
PCT/IB2017/054221 WO2018015845A1 (en) 2016-07-16 2017-07-12 Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide

Publications (1)

Publication Number Publication Date
LT3484907T true LT3484907T (lt) 2020-09-10

Family

ID=59656110

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17754482.2T LT3484907T (lt) 2016-07-16 2017-07-12 Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas

Country Status (13)

Country Link
US (1) US10696709B2 (lt)
EP (1) EP3484907B1 (lt)
CY (1) CY1123516T1 (lt)
DK (1) DK3484907T3 (lt)
ES (1) ES2820242T3 (lt)
HR (1) HRP20201274T1 (lt)
HU (1) HUE051312T2 (lt)
LT (1) LT3484907T (lt)
PL (2) PL417980A1 (lt)
PT (1) PT3484907T (lt)
RS (1) RS60848B1 (lt)
SI (1) SI3484907T1 (lt)
WO (1) WO2018015845A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023250528A1 (en) * 2022-06-24 2023-12-28 The Broad Institute, Inc. Compositions and methods for preparing capped circular rna molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969545B2 (en) 2011-10-18 2015-03-03 Life Technologies Corporation Alkynyl-derivatized cap analogs, preparation and uses thereof

Also Published As

Publication number Publication date
PL417980A1 (pl) 2018-01-29
PT3484907T (pt) 2020-09-17
RS60848B1 (sr) 2020-10-30
US20200055891A1 (en) 2020-02-20
EP3484907B1 (en) 2020-05-13
HUE051312T2 (hu) 2021-03-01
PL3484907T3 (pl) 2021-02-08
HRP20201274T1 (hr) 2020-12-11
SI3484907T1 (sl) 2020-12-31
DK3484907T3 (da) 2020-08-17
ES2820242T3 (es) 2021-04-20
EP3484907A1 (en) 2019-05-22
WO2018015845A1 (en) 2018-01-25
US10696709B2 (en) 2020-06-30
CY1123516T1 (el) 2022-03-24

Similar Documents

Publication Publication Date Title
IL256395B (en) Stabilized antimicrobial peptides, preparations containing them and methods of producing them
WO2017024317A3 (en) Methods to induce targeted protein degradation through bifunctional molecules
SG10202110491PA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
IL258202B (en) CD3-binding polypeptides, method for their preparation, pharmaceutical preparations, nucleic acids, vectors and use of such polypeptides
IL290633A (en) 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses
HK1243424A1 (zh) 4'-硫代核苷的新型化合物及其製備方法、藥物組合物和應用
WO2015006747A3 (en) Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
WO2016149455A3 (en) The rna interactome of polycomb repressive complex 1 (prc1)
WO2016205531A3 (en) Anti-her2 antibodies and methods of use
WO2016033315A3 (en) Synthon formation
WO2016065349A8 (en) Short non-coding protein regulatory rnas (sprrnas) and methods of use
EP3596104A4 (en) COMPOSITIONS OF PEDF-DERIVED SHORT PEPTIDES AND USES THEREOF
WO2017025179A8 (en) A transglutamine tag for efficient site-specific bioconjugation
EP3543335A3 (en) Soluble intein fusion proteins and methods for purifying biomolecules
WO2015011694A3 (en) Isotopologues of smad7 antisense oligonucleotides
WO2018226992A8 (en) Tau aggregation inhibitors
EP3560950A4 (en) NOVEL MUTANT OF ALFA-CONOTOXIN-PEPTIDE-TXID, PHARMACEUTICAL COMPOSITION AND USE OF IT
PL3408276T3 (pl) 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania
EP3302468A4 (en) SMALL MOLECULE ANALOGUES OF THE NEMO BINDING PEPTIDE
WO2016020882A3 (en) Angiopoetin-like 4 (angptl4) antibodies and methods of use
WO2016020880A3 (en) Angiopoietin-like 4 antibodies and methods of use
IL284333A (en) Oligomeric nucleic acid molecule and its use
EP3650464A4 (en) PEPTIDIC COMPOUND AND ITS APPLICATION, AND COMPOSITION CONTAINING A PEPTIDIC COMPOUND
WO2018132821A3 (en) Elastomeric proteins
EP3536701A4 (en) NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR INHIBITION OF AGING OF THE SKIN OR THE FORMATION OF WRINKLES CONTAINING IT